Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cognizant
CTSH
$26B
| $167M | 0.04% |
2,011,060
+188,331
| +10% | +$14.1M |
|
327
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
| $167M | 0.04% |
870,800
+47,500
| +6% | +$9.02M |
|
328
Williams Companies
WMB
$86.1B
| $167M | 0.04% |
2,774,261
+36,746
| +1% | +$2.22M |
|
329
PUT
Citigroup
C
$226B
| $167M | 0.04% |
1,427,600
-174,500
| -11% | -$18.1M |
|
330
Nu Holdings
NU
$66.9B
| $165M | 0.04% |
9,855,032
-1,933,990
| -16% | -$31.1M |
|
331
PUT
Alibaba
BABA
$308B
| $164M | 0.04% |
1,121,000
+94,300
| +9% | +$15.4M |
|
332
PUT
CrowdStrike
CRWD
$218B
| $164M | 0.04% |
1,396,400
+636,800
| +84% | +$81.1M |
|
333
Zscaler
ZS
$27.3B
| $164M | 0.04% |
727,417
+87,471
| +14% | +$24.7M |
|
334
Murphy USA
MUSA
$9.61B
| $163M | 0.04% |
405,148
-19,670
| -5% | -$7.55M |
|
335
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $163M | 0.04% |
1,965,902
+459,760
| +31% | +$38.1M |
|
336
Emcor
EME
$36B
| $160M | 0.04% |
262,280
+137,238
| +110% | +$88.9M |
|
337
United Parcel Service
UPS
$88.9B
| $160M | 0.04% |
1,616,032
-418,657
| -21% | -$39.2M |
|
338
Kroger
KR
$34.8B
| $160M | 0.04% |
2,565,269
-778,836
| -23% | -$50.9M |
|
339
Datadog
DDOG
$84B
| $159M | 0.04% |
1,172,600
+54,946
| +5% | +$8.68M |
|
340
PUT
Wheaton Precious Metals
WPM
$60.9B
| $159M | 0.04% |
1,350,000
| – | – |
|
341
Millicom
TIGO
$16.3B
| $159M | 0.04% |
2,860,379
-34,836
| -1% | -$1.75M |
|
342
CALL
Arm
ARM
$302B
| $157M | 0.04% |
1,439,900
+14,600
| +1% | +$2.12M |
|
343
Public Storage
PSA
$61.3B
| $157M | 0.04% |
603,838
+879
| +0.1% | +$246K |
|
344
Praxis Precision Medicines
PRAX
$10.1B
| $156M | 0.04% |
530,751
+454,114
| +593% | +$84.6M |
|
|
MICC
345
The Magnum Ice Cream Company N.V.
MICC
$11.8B
| $156M | 0.04% |
+9,862,859
| New | +$155M |
|
346
CoStar Group
CSGP
$12.3B
| $156M | 0.04% |
2,321,700
+1,055,584
| +83% | +$74.8M |
|
347
Verisk Analytics
VRSK
$25B
| $156M | 0.04% |
696,419
-165,502
| -19% | -$37.3M |
|
348
Carlisle Companies
CSL
$15.4B
| $155M | 0.04% |
485,801
-13,540
| -3% | -$4.39M |
|
349
SLB Ltd
SLB
$75B
| $154M | 0.04% |
4,012,762
-535,899
| -12% | -$19.4M |
|
350
Truist Financial
TFC
$64B
| $153M | 0.04% |
3,102,435
-679,198
| -18% | -$31.3M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.